Micro and Nanotechnologies in Engineering Stem Cells and Tissues

MURUGAN RAMALINGAM, PhD, is Associate Professor in the Centre for Stem Cell Research (a unit of Institute for Stem Cell Biology and Regenerative Medicine, Bengaluru) at the Christian Medical College, Vellore, India. He is well known for his pioneering work on gradient biomaterials, stem cell engineering, and soft-to-hard interface tissue engineering. ESMAIEL JABBARI, PhD, is Associate Professor of Chemical and Biomedical Engineering and Adjunct Professor of Orthopedic Surgery at the University of South Carolina. An internationally known researcher, he has published extensively on biomaterials, drug delivery, and tissue engineering. SEERAM RAMAKRISHNA, PhD, is Professor of Mechanical Engineering and Bioengineering at the National University of Singapore. He is well known for his pioneering work on electrospinning of nanofibers. ALI KHADEMHOSSEINI, PhD, is Associate Professor at the Harvard-MIT Division of Health Sciences and Technology, Brigham and Women's Hospital, and Harvard Medical School.

1 Stem cells and nanotechnology in tissue engineering and regenerative medicines. 2 Nanofiber technology for controlling stem cell functions and tissue engineering. 3 Micro and nanoengineering approaches to developing gradient biomaterials suitable for interface tissue engineering. 4 Microengineered polymer and ceramic based biomaterial scaffolds: A topical review on design, processing and biocompatibility properties. 5 Synthetic enroutes to engineer electrospun scaffolds for stem cells and tissue regeneration. 6 Integrating top down and bottom up scaffolding tissue engineering approach for bone regeneration. 7 Characterization of the adhesive interactions between cells and biomaterials. 8 Microfluidic formation of cell laden hydrogel modules for tissue engineering. 9 Micro and nanospheres for tissue engineering. 10 Micro and nano technologies to engineer bone regeneration. 11 Micro and nanotechnology for vascular tissue engineering. 12 Application of stem cells in ischemic heart disease.